Quick Answer
Raphael Pharmaceutical Inc. reported Total Assets of $53.0 thousand for fiscal year 2025.
Raphael Pharmaceutical Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $53.0K | +96.3% |
| 2024 | $27.0K | -88.7% |
| 2023 | $239.0K | -28.2% |
| 2022 | $333.0K | -21.1% |
| 2021 | $422.0K | +30.7% |
| 2020 | $323.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.0K | -86.3% | -76.7% |
| June 30, 2025 | $30.0K | -76.6% | -67.7% |
| March 31, 2025 | $93.0K | -73.7% | +244.4% |
| December 31, 2024 | $27.0K | -92.0% | -47.1% |
| September 30, 2024 | $51.0K | -87.3% | -60.2% |
| June 30, 2024 | $128.0K | +7.6% | -63.7% |
| March 31, 2024 | $353.0K | +135.3% | +4.1% |
| December 31, 2023 | $339.0K | +1.8% | -15.9% |
- Raphael Pharmaceutical Inc. showed an increase of +96.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Raphael Pharmaceutical Inc.’s total assets has declined by 83.6% (from $323.0 thousand to $53.0 thousand).
- The most recent figure is from Raphael Pharmaceutical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: